North America Anaphylaxis Treatment Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Medication Type (Epinephrine, Antihistamines, Steroids, Beta-Agonist, and Others), Route of Administration (Oral, Parenteral, and Others), Allergy Type (Food Allergy, Medications, Insect Stings, and Others) and Distribution Channel (Hospital Pharmacies, Retail Sales, and Others)

No. of Pages: 143    |    Report Code: TIPRE00023954    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Anaphylaxis Treatment Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Anaphylaxis Treatment Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Anaphylaxis Treatment Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1
  • 5.1.2 Rising Incidence of Anaphylaxis
  • 5.1.3 Growing awareness and education about anaphylaxis management among healthcare providers and patients.
  • 5.1.4 Advancements in auto-injector technologies improving accessibility and ease of use for emergency treatment.
5.2 Market Opportunities
  • 5.2.1
  • 5.2.2 Development of new formulations and delivery systems for more effective anaphylaxis treatments.
  • 5.2.3 Expansion of training programs and resources for schools and workplaces to improve preparedness for anaphylaxis incidents.
  • 5.2.4 Opportunities for partnerships between pharmaceutical companies and healthcare organizations for awareness campaigns and product distribution.
5.3 Future Trends
  • 5.3.1
  • 5.3.2 Increasing focus on personalized medicine approaches for allergy management and anaphylaxis prevention.
  • 5.3.3 Integration of digital health technologies, such as mobile apps, for tracking and managing allergic reactions.
  • 5.3.4 Growing emphasis on research and development for novel therapies targeting underlying causes of allergies.
5.4 Impact of Drivers and Restraints

6. North America Anaphylaxis Treatment Market Regional Analysis

6.1 North America Anaphylaxis Treatment Market Overview
6.2 North America Anaphylaxis Treatment Market Revenue 2019-2028 (US$ Million)
6.3 North America Anaphylaxis Treatment Market Forecast Analysis

7. North America Anaphylaxis Treatment Market Analysis – by Medication Type

7.1 Epinephrine
  • 7.1.1 Overview
  • 7.1.2 Epinephrine: North America Anaphylaxis Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Antihistamines
  • 7.2.1 Overview
  • 7.2.2 Antihistamines: North America Anaphylaxis Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Steroids
  • 7.3.1 Overview
  • 7.3.2 Steroids: North America Anaphylaxis Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Beta-Agonist
  • 7.4.1 Overview
  • 7.4.2 Beta-Agonist: North America Anaphylaxis Treatment Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Anaphylaxis Treatment Market Analysis – by Route of Administration

8.1 Oral
  • 8.1.1 Overview
  • 8.1.2 Oral: North America Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Parenteral
  • 8.2.1 Overview
  • 8.2.2 Parenteral: North America Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Anaphylaxis Treatment Market Analysis – by Allergy Type

9.1 Food Allergy
  • 9.1.1 Overview
  • 9.1.2 Parenteral: North America Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Medications
  • 9.2.1 Overview
  • 9.2.2 Parenteral: North America Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Insect Stings
  • 9.3.1 Overview
  • 9.3.2 Parenteral: North America Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Anaphylaxis Treatment Market – North America Analysis

10.1 North America
  • 10.1.1 North America Anaphylaxis Treatment Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America Anaphylaxis Treatment Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Anaphylaxis Treatment Market Breakdown, by Medication Type
    • 10.1.1.1.2 US: North America Anaphylaxis Treatment Market Breakdown, by Route of Administration
    • 10.1.1.1.3 US: North America Anaphylaxis Treatment Market Breakdown, by Allergy Type
  • 10.1.1.2 Canada: North America Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Anaphylaxis Treatment Market Breakdown, by Medication Type
    • 10.1.1.2.2 Canada: North America Anaphylaxis Treatment Market Breakdown, by Route of Administration
    • 10.1.1.2.3 Canada: North America Anaphylaxis Treatment Market Breakdown, by Allergy Type
  • 10.1.1.3 Mexico : North America Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Anaphylaxis Treatment Market Breakdown, by Medication Type
    • 10.1.1.3.2 Mexico : North America Anaphylaxis Treatment Market Breakdown, by Route of Administration
    • 10.1.1.3.3 Mexico : North America Anaphylaxis Treatment Market Breakdown, by Allergy Type

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Anaphylaxis Treatment Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Amneal Pharmaceuticals Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Mylan N.V.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Adamis Pharmaceutical Corporation
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Abbott
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Pfizer Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Glaxosmithkline Plc.,
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Merck And Co., Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Teva Pharmaceutical Industries Ltd.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 ALK-ABELLó
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Anaphylaxis Treatment Market

  1. Amneal Pharmaceuticals Inc.
  2. Mylan N.V.
  3. Adamis Pharmaceutical Corporation
  4. Abbott
  5. Pfizer Inc.
  6. Glaxosmithkline Plc.,
  7. Merck And Co., Inc.
  8. Teva Pharmaceutical Industries Ltd.        
  9. ALK-ABELLó   
north-america-anaphylaxis-treatment-market